DBL Potassium Dihydrogen Phosphate Contraindications

DBL Potassium Dihydrogen Phosphate Concentrated Injection is contraindicated in: Patients with severe renal function impairment (less than 30% normal) since there is an increased risk of hyperphosphataemia in these patients.
Patients with hyperphosphataemia, since phosphate therapy will exacerbate the condition.
Patients with hypocalcaemia due to the close relationship between hypocalcaemia and hyperphosphataemia.
Patients with hyperkalaemia, since the potassium in the injection may exacerbate the condition.
Addison's disease since there is an increased risk of hyperkalaemia in these patients.
Urolithiasis (magnesium ammonium phosphate type, infected) since it may exacerbate the condition.
Renal impairment with oliguria and azotaemia.
Ventricular fibrillation.
Hyperadrenalism associated with adrenogenital syndrome.
Extensive tissue breakdown as in severe burns.
Acute dehydration.
Heat cramps.
Increased sensitivity to potassium administration as in adynamia episodica hereditaria or congenital paramytonia.